SCHEMBL20103399

SCHEMBL20103399

COC(=O)CC(c1cccc(OC)c1)C1CC1

nearest known ligand 0.57

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 16/20 0.57
L3MBTL1 Q9Y468 1/20 0.50
POLB P06746 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20103535 0.88 FFAR1 (0.71) FFAR1
SCHEMBL12191933 0.88 FFAR1 (0.71) FFAR1
SCHEMBL12191936 0.88 FFAR1 (0.71) FFAR1
SCHEMBL2504416 0.85 OPRD1 (0.48) FFAR1
SCHEMBL29454583 0.85 OPRD1 (0.48) FFAR1
SCHEMBL18501542 0.85 FFAR1 (0.43) FFAR1
SCHEMBL2501419 0.85 OPRD1 (0.48) FFAR1
SCHEMBL18501544 0.85 FFAR1 (0.43) FFAR1
SCHEMBL30533375 0.85 OPRD1 (0.48) FFAR1
SCHEMBL29454615 0.85 OPRD1 (0.48) FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018081047-A1 CYCLOHEXYL GPR40 AGONISTS FOR THE TREATMENT OF TYPE II DIABETES JANSSEN PHARMACEUTICA NV (BE) 2018-05-03 WO disclosed